MedPath

UNIVERSITY OF SOUTHERN CALIFORNIA

UNIVERSITY OF SOUTHERN CALIFORNIA logo
🇺🇸United States
Ownership
Private
Established
1880-01-01
Employees
10K
Market Cap
-
Website
http://startusc.com

Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer

Active, not recruiting
Conditions
Healthy Subject
Recurrent Renal Cell Carcinoma
Stage I Renal Cell Cancer
Metastatic Renal Cell Cancer
Stage II Renal Cell Cancer
Stage III Renal Cell Cancer
Interventions
Procedure: Computed Tomography
Other: Cytology Specimen Collection Procedure
Other: Laboratory Biomarker Analysis
Procedure: Magnetic Resonance Imaging
First Posted Date
2016-01-27
Last Posted Date
2024-05-02
Lead Sponsor
University of Southern California
Target Recruit Count
37
Registration Number
NCT02664883
Locations
🇺🇸

USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

Nanopulse Efficacy Study for the Treatment of Common Warts

Not Applicable
Completed
Conditions
Common Warts
Interventions
Device: Nanopulse System
First Posted Date
2016-01-08
Last Posted Date
2019-08-06
Lead Sponsor
University of Southern California
Target Recruit Count
24
Registration Number
NCT02650466
Locations
🇺🇸

Huntington Medical Foundation, Pasadena, California, United States

Effects of Intranasal Oxytocin on Cigarette Smoking

Phase 4
Completed
Conditions
Nicotine Dependence
Tobacco Smoking
Interventions
Drug: Oxytocin
Drug: Placebo
First Posted Date
2015-11-03
Last Posted Date
2021-11-15
Lead Sponsor
University of Southern California
Target Recruit Count
83
Registration Number
NCT02595749
Locations
🇺🇸

USC Health, Emotion and Addiction Laboratory, Los Angeles, California, United States

Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI

Not Applicable
Completed
Conditions
Stage IA Breast Cancer
Stage II Breast Cancer
Stage IB Breast Cancer
Ductal Breast Carcinoma In Situ
Interventions
Procedure: Contrast-enhanced Magnetic Resonance Imaging
Procedure: Mammography
Procedure: Therapeutic Conventional Surgery
Procedure: Ultrasonography
Other: Gadolinium
First Posted Date
2015-10-27
Last Posted Date
2019-05-16
Lead Sponsor
University of Southern California
Target Recruit Count
300
Registration Number
NCT02587663
Locations
🇺🇸

USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

Donor Cellular Therapy After Cytarabine in Treating Patients With Intermediate-Risk Acute Myeloid Leukemia in Remission

Phase 2
Withdrawn
Conditions
Adult Acute Myeloid Leukemia in Remission
Childhood Acute Myeloid Leukemia in Remission
Interventions
Drug: Cytarabine
Other: Laboratory Biomarker Analysis
Procedure: Peripheral Blood Stem Cell Transplantation
Biological: Therapeutic Allogeneic Lymphocytes
Biological: G-CSF mobilized peripheral blood cells
First Posted Date
2015-10-27
Last Posted Date
2018-11-09
Lead Sponsor
University of Southern California
Registration Number
NCT02587871
Locations
🇺🇸

USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

Musculoskeletal Health of the Upper Extremity in Emerging Health Professionals

Completed
Conditions
Carpal Tunnel Syndrome
Interventions
Other: Academic Coursework
Other: Work-Related Hand Activities
First Posted Date
2015-10-27
Last Posted Date
2023-09-28
Lead Sponsor
University of Southern California
Target Recruit Count
176
Registration Number
NCT02587897
Locations
🇺🇸

Loma Linda Univeristy Dental Hygiene Program, Loma Linda, California, United States

🇺🇸

USC Musculsokeletal Sonography & Occupational Performance Laboratory, Los Angeles, California, United States

🇺🇸

USC Dental Hygiene, Los Angeles, California, United States

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

Phase 1
Completed
Conditions
Localized Resectable Adult Liver Carcinoma
Adult Hepatocellular Carcinoma
BCLC Stage B Adult Hepatocellular Carcinoma
BCLC Stage 0 Adult Hepatocellular Carcinoma
BCLC Stage C Adult Hepatocellular Carcinoma
BCLC Stage D Adult Hepatocellular Carcinoma
Advanced Adult Hepatocellular Carcinoma
BCLC Stage A Adult Hepatocellular Carcinoma
Localized Non-Resectable Adult Liver Carcinoma
Interventions
Drug: Gadoxetate Disodium
Device: Magnetic Resonance Imaging
First Posted Date
2015-10-19
Last Posted Date
2015-10-19
Lead Sponsor
University of Southern California
Target Recruit Count
26
Registration Number
NCT02578602
Locations
🇺🇸

USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

Sitagliptin Effects on Arterial Vasculature and Inflammation in Obesity

Phase 2
Completed
Conditions
Inflammation
Atherosclerosis
Interventions
Drug: Placebo
Drug: Sitagliptin
First Posted Date
2015-10-15
Last Posted Date
2019-07-17
Lead Sponsor
University of Southern California
Target Recruit Count
21
Registration Number
NCT02576288
Locations
🇺🇸

University of Southern California Health Sciences Campus, Los Angeles, California, United States

Fasting-mimicking Diet and Immunosenescence

Phase 2
Withdrawn
Conditions
Immunosenescence
Interventions
Biological: Seasonal influenza (flu) vaccine
Other: Diet
First Posted Date
2015-09-18
Last Posted Date
2019-10-30
Lead Sponsor
University of Southern California
Registration Number
NCT02554188

Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy

Not Applicable
Terminated
Conditions
Malignant Digestive System Neoplasm
Nausea and Vomiting
Interventions
First Posted Date
2015-09-15
Last Posted Date
2017-03-28
Lead Sponsor
University of Southern California
Target Recruit Count
19
Registration Number
NCT02550119
Locations
🇺🇸

USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath